Neuromodulation therapy for refractory psychosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061115

Enrollment

Unknown

Registered

2022-06-15

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory psychosis

Interventions

DBS group:DeepBrain Stimulation

SRFA group:Stereotactic radio frequency ablation

VNS group:vagal nerve stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the relevant diagnostic criteria in DSM-5; 2. The effect of preoperative systematic treatment was poor; 3. In good general condition, voluntarily participate in and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. complicated with malignant tumor; 2. Cannot tolerate surgery; 3. complicated with serious underlying diseases; 4. Contraindications of stereotactic neurosurgery.

Design outcomes

Primary

Measure	Time frame
Psychological scale;cognitive test;	—

Countries

China

Contacts

Public ContactLou tao

The Second Affiliated Hospital of Xinxiang Medical College

Loutao369@126.com+86 13598621962

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026